LILRB2 and Hepatic steatosis: Combines with LILRB-2 on macrophages and enhances the conversion of hepatic macrophages to M1 subtype; primarily driven by p38/Akt/p65 phosphorylation; promotes lipid accumulation and enhances progression from simple hepatic steatosis to steatohepatitis